Análise científica e tecnológica de patentes sobre dengue e H1N1: comparativo entre doença tropical negligenciada e não negligenciada

Abstract

Technological advancement is an important strategy for world economic and social development. In this context, innovation is highlighted and directly linked to the number of patent deposits for the pathologies dengue and influenza A (H1N1). A comparison between the two diseases, one considered a neglected tropical disease and the other not, in the period from 2001 to 2016, was performed using the Derwent Innovations Index database as source of information. The factors analyzed were geographic distribution of the registrations; the typology (depositor); the description of the applications according to the International Patent Classification; the technological focus and the temporal evolution of patent applications in the period of the research. When using the term "dengue", 2660 patent families were found, while "H1N1" found 1103 families. When verifying the geographical distribution, it was verified domination of the United States in both pathologies. For the thematic trend of innovations, from the CIP, the predominance was found for the section "Human Needs", with "Medical or Veterinary Science and Hygiene" at the class level and for the subclass, the most predominant were "Therapeutic activity specific for chemical compounds or medical preparations "and" Preparations for medical, dental or hygienic purposes ". Analyzing the annual time evolution, it is observed that the average for dengue was 177 patents per year, with an increase of 22.43 and a negative acceleration, after 2007, of 1.40 annually. And for H1N1, the annual average was 88.57 patents, an increase of 21.19 and a negative acceleration of 1.02 a year. Monitoring by means of the analysis of the patent registry is a fundamental contribution to making decisions that have an impact on the world public health situation, such as the right to health and access to services, especially in developing countries.